Stable bone mineral density in lumbar spine and hip in contrast to bone loss in the hands during long-term treatment with infliximab in patients with rheumatoid arthritis.
Eekman
Danielle A
DA
Vis
Marijn
M
Bultink
Irene E M
IE
Kuik
Dirk J
DJ
Voskuyl
Alexandre E
AE
Dijkmans
Ben A C
BA
Lems
Willem F
WF
D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D015519:Bone Density / Q000187:drug effects*; D005260:Female; D050823:Hand Joints / Q000503:physiopathology; D006621:Hip Joint / Q000503:physiopathology; D006801:Humans; D000069285:Infliximab; D008159:Lumbar Vertebrae / Q000503:physiopathology; D008297:Male; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab